• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, January 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Timing of Medicare loss may affect long-term success of kidney transplantation

Bioengineer by Bioengineer
March 6, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Kidney transplant recipients under 65 years of age qualify for Medicare coverage following transplantation, but coverage ends after three years. A new American Journal of Transplantation study found that failure of the transplanted kidney was 990 percent to 1630 percent higher for recipients who lost Medicare coverage before this three-year time point compared with recipients who lost Medicare on time. Those who lost coverage after this point had a lesser, but still marked, increased risk of kidney failure.

Recipients who lost coverage before or after the three-year time point also filled immunosuppressive medications at a significantly lower rate than those who lost coverage on time.

The study included 78,861 Medicare-covered kidney transplant recipients under 65 years of age.

The findings have significant policy implications, and they suggest that a close examination of the risks of Medicare loss, as well as the importance of medical coverage safety nets and access to immunosuppressive medications, must be examined.

“Kidney transplantation has profound survival, quality of life, and cost benefits over dialysis for the treatment of end-stage kidney disease, and yet thousands of patients die every year while waiting for a kidney because it is such a scarce resource,” said lead author Dr. Allyson Hart, of Hennepin Healthcare and the University of Minnesota, in Minneapolis. “Our findings strongly suggest that we need to more closely evaluate the health care system we have in place to make sure these transplanted patients don’t end up back on dialysis simply because they can’t afford the care they need.”

###

Media Contact
Penny Smith
[email protected]
http://dx.doi.org/10.1111/ajt.15293

Tags: Medicine/HealthPublic HealthSocioeconomicsTransplantation
Share13Tweet8Share2ShareShareShare2

Related Posts

Developing Eye Care Guidelines for Prone Ventilation

January 11, 2026

Guillain-Barré Syndrome Linked to TNF Inhibitor in Blau

January 11, 2026

Dual Nanocarriers Target Smad3 and Runx2 in Aortic Valve Disease

January 11, 2026

Psychological Resilience Eases Loneliness in Caregivers

January 11, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    154 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    146 shares
    Share 58 Tweet 37
  • Robotic Ureteral Reconstruction: A Novel Approach

    50 shares
    Share 20 Tweet 13
  • Impact of Vegan Diet and Resistance Exercise on Muscle Volume

    47 shares
    Share 19 Tweet 12
v>

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Developing Eye Care Guidelines for Prone Ventilation

Guillain-Barré Syndrome Linked to TNF Inhibitor in Blau

Dual Nanocarriers Target Smad3 and Runx2 in Aortic Valve Disease

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.